文献速递神经肿瘤

尼泊尔脑膜瘤术后临床结局与复发:单中心回顾性研究

Clinical Outcome and Recurrence After Meningioma Surgery: An Experience from a Developing Country, Nepal.
PubMed 文献 · World Neurosurg · 2020-12-24

该研究回顾性分析了2007至2019年尼泊尔Mediciti医院233例新诊断颅内脑膜瘤手术患者,评估术后结局与复发。94.8%患者预后良好,复发率6.9%,肿瘤大小、切除程度、合并症与预后相关,年龄和WHO分级与复发独立相关。

要点

  • 全切(SM 0-III)率达85.4%,预后良好率94.8%,复发率6.9%。
  • 肿瘤<3 cm、全切及合并症与良好预后显著相关。
  • 年龄和WHO分级是复发的独立相关因素。

核心结论

  • 肿瘤大小、切除程度、年龄、肿瘤分级和合并症与脑膜瘤术后结局显著相关。
  • 作者建议开展采用标准化随访方案的前瞻性研究以评估长期结局。

研究设计与样本

  • 单中心回顾性研究,纳入2007至2019年尼泊尔Mediciti医院新诊断颅内脑膜瘤手术患者233例。
  • 采用logistic回归模型计算校正比值比(AOR)及95%CI。

主要发现

  • 233例患者平均年龄47岁,女性受累约为男性两倍;83.3%位于幕上,83.7%肿瘤大于5 cm。
  • 全切(SM 0-III)达85.4%,98.7%为WHO I级,预后良好(mRS≤3)占94.8%,复发率6.9%。
  • 并发症率30%,手术死亡率1.72%。
  • 肿瘤<3 cm(AOR 0.024,95%CI 0.001-0.416,P=0.010)、全切(AOR 19.737,95%CI 4.69-83.063,P<0.001)、合并症(AOR 0.202,95%CI 0.052-0.785,P=0.021)与良好预后显著相关。
  • 年龄(AOR 3.491,95%CI 1.029-11.850,P=0.045)和WHO分级(AOR 0.024,95%CI 0.002-0.344,P=0.006)与复发独立相关。

临床怎么用

  • 术后预后评估可结合肿瘤大小、切除程度、年龄、WHO分级和合并症进行风险分层。
  • 对高龄及高级别脑膜瘤患者应加强复发监测与随访。

局限性

  • 为单中心回顾性研究,作者建议未来开展标准化随访的前瞻性研究以评估长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Meningioma is the most common primary brain tumor, constituting more than half of all benign central nervous system tumors. This study aims to analyze the clinical outcome and recurrence after surgery of intracranial meningioma in Nepal. METHODS: This is a retrospective study of newly diagnosed intracranial meningioma patients operated at Nepal Mediciti Hospital between 2007 and 2019. Demographics; clinical, radiologic, and perioperative details; histopathology; and clinical outcome variables were reviewed. Association of independent variables with primary outcome variables: modified Rankin Scale (favorable [≤ 3] vs. unfavorable [>3]) and recurrence was analyzed. Logistic regression model was designed to calculate adjusted odds ratio with 95% confidence interval (CI). RESULTS: Of 233 patients, mean age was 47 years, female individuals were affected twice as much as male individuals. Location was supratentorial in 83.3%, 83.7% had tumor greater than 5 cm in size. Gross total resection (SM 0-III) was achieved in 85.4%. A total of 98.7% had grade I meningioma. Favorable outcome was found in 94.8%. Recurrence rate was 6.9%. Tumor size less than 3 cm (adjusted odds ratio [AOR] 0.024 95% CI 0.001-0.416, P = 0.010), gross total resection (AOR 19.737, 95% CI 4.69-83.063, P < 0.001), and comorbidity (AOR 0.202, 95% CI 0.052-0.785, P = 0.021) were significantly associated with favorable outcome whereas age (AOR 3.491, 95% CI 1.029-11.850, P = 0.045) and WHO grade (AOR 0.024, 95% CI 0.002-0.344, P = 0.006) were independently associated with recurrence. The complication and surgical mortality rates were 30% and 1.72%, respectively. CONCLUSIONS: Tumor size, extent of resection, age, tumor grade, and medical comorbidities were significantly associated with postoperative outcome. We recommend a prospective study with standardized follow up protocol to assess the long-term outcome.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Raman SG, Prakash P, Sumit J, et al. Clinical Outcome and Recurrence After Meningioma Surgery: An Experience from a Developing Country, Nepal. World Neurosurg. 2020. PMID: 33359878. doi:10.1016/j.wneu.2020.12.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。